We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments. Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go: Expired investment: Withheld
Speeding up access to mental health treatments by using electronic forms and universal communication tools. Thalamos has created a solution for multiple health entities such as the NHS, social services, charities, etc. The company aims to move these entities away from pen and paper, to an easy-to-use online platform, as manual entries are prone to information and data being misplaced, as well as prone to errors. Thalamos's cloud platform will enable psychiatrists to reduce their clinical and information governance risk, whilst helping to continuously improve their patients' recovery process. The product will be subscription-based from £600 per year, which can be paid monthly and is in-line with other professional services.
days to go: Expired investment: £171,548
Please watch the video for more information
days to go: Expired investment: £1,579,480
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings. 
days to go: Expired investment: £1,126,464
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices.  Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.  
days to go: Expired investment: £167,910
United Medicine have created a platform where experience, knowledge and opinion of their medical users is used to provide a global consensus and allows the good evidence to be separated from the bad.   
days to go: Expired investment: £152,000
Uproot is an e-commerce platform that offers a diverse selection of organic and sustainable products. Born from reflections during the pandemic, it challenges the superficial pursuits driven by societal pressures. Uproot questions the effects of consumerism on our lives and the environment, aiming to establish a space where mindful choices and natural goodness thrive. By uniting a community of individuals dedicated to positive transformation, Uproot seeks to align human existence with the planet, promoting renewal and revitalization for both people and the Earth.
days to go: Expired investment: Withheld
Delivering safe and clean drinking water by using nanotechnology to produce eco-friendly and recyclable filters. Water to Go has developed a portable 750ml filter that is equivalent to using more than 400 water bottles designed for single-use and made from plastic. Water to Go's technology has been tested in multiple laboratories across the globe and the company has planned to integrate their product into more applications. Their filter initially launched on Amazon.com and is currently available in over 50 countries worldwide. Clients include Boots, Millets, Go Outdoors and Blacks amongst others. Repeat sales of the filter is currently the main source of revenue.
days to go: Expired investment: £276,580
aterhaul converts harmful ocean plastic, specifically ghost gear, into high-quality eyewear and adventure-oriented products. With £2 million in revenue, notable collaborations, and praise from Sir David Attenborough, we're seeking funding to propel our next phase of growth, expand our reach, and increase our positive influence. Through recovering, recycling, and redesigning ghost gear into premium eyewear, we're turning waste into value while engaging a community through our recycled litter picking equipment to join us in our mission.
days to go: Expired investment: £596,567
WokenUp is a revolutionary global social network focused on empowering users to work together to meet the 17 United Nations Sustainable Development Goals by 2030. It aims to transform humanity for good by bringing together the individuals, companies, and charities that are doing good in the world and who are willing to make a difference in social and environmental causes. WokenUp has a unique feature called Snippets with which users can demonstrate how a company or charity is making a positive impact. The company is targeting revenues from job spec fees, advertising, & premium subscriptions. With the proceeds, WokenUp seeks to allow its users to increase the impact that they are making.
days to go: Expired investment: £128,460
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph